ENSG00000177469


Homo sapiens

Features
Gene ID: ENSG00000177469
  
Biological name :CAVIN1
  
Synonyms : caveolae associated protein 1 / CAVIN1 / Q6NZI2
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 17
Strand: -1
Band: q21.2
Gene start: 42402452
Gene end: 42423517
  
Corresponding Affymetrix probe sets: 1557938_s_at (Human Genome U133 Plus 2.0 Array)   208789_at (Human Genome U133 Plus 2.0 Array)   208790_s_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000349541
NCBI entrez gene - 284119     See in Manteia.
OMIM - 603198
RefSeq - NM_012232
RefSeq Peptide - NP_036364
swissprot - Q6NZI2
Ensembl - ENSG00000177469
  
Related genetic diseases (OMIM): 613327 - Lipodystrophy, congenital generalized, type 4, 613327
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 cavin1aENSDARG00000076411Danio rerio
 cavin1bENSDARG00000059362Danio rerio
 PTRFENSGALG00000003261Gallus gallus
 Cavin1ENSMUSG00000004044Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
CAVIN2 / O95810 / caveolae associated protein 2ENSG0000016849735
CAVIN4 / Q5BKX8 / caveolae associated protein 4ENSG0000017068126
CAVIN3 / Q969G5 / caveolae associated protein 3ENSG0000017095519


Protein motifs (from Interpro)
Interpro ID Name
 IPR026752  Cavin family
 IPR033297  Caveolae-associated protein 1


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006351 transcription, DNA-templated IEA
 biological_processGO:0006353 DNA-templated transcription, termination IEA
 biological_processGO:0006355 regulation of transcription, DNA-templated IEA
 biological_processGO:0006361 transcription initiation from RNA polymerase I promoter IDA
 biological_processGO:0006363 termination of RNA polymerase I transcription IDA
 biological_processGO:0009303 rRNA transcription IEA
 biological_processGO:2000147 positive regulation of cell motility IEA
 cellular_componentGO:0005634 nucleus IEA
 cellular_componentGO:0005654 nucleoplasm TAS
 cellular_componentGO:0005737 cytoplasm IEA
 cellular_componentGO:0005739 mitochondrion IEA
 cellular_componentGO:0005783 endoplasmic reticulum IEA
 cellular_componentGO:0005829 cytosol IEA
 cellular_componentGO:0005886 plasma membrane IEA
 cellular_componentGO:0005901 caveola IDA
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0032991 protein-containing complex IDA
 cellular_componentGO:0043231 intracellular membrane-bounded organelle IEA
 cellular_componentGO:0045121 membrane raft IDA
 molecular_functionGO:0003723 RNA binding IEA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0019843 rRNA binding IEA
 molecular_functionGO:0042134 rRNA primary transcript binding IDA
 molecular_functionGO:0042802 identical protein binding IPI


Pathways (from Reactome)
Pathway description
RNA Polymerase I Transcription Termination


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000147 polycystic ovaries 
Show

 HP:0000819 Diabetes mellitus 
Show

 HP:0000824 Growth hormone deficiency "Insufficient production of growth hormone, which is produced by the anterior pituitary gland." [HPO:curators]
Show

 HP:0000842 Hyperinsulinemia 
Show

 HP:0000855 Insulin resistance 
Show

 HP:0000869 Secondary amenorrhea 
Show

 HP:0000938 Osteopenia "Osteopenia refers to a reduction in bone mineral density (BMD) below normal peak BMD but not low enough to be classified as osteoporosis. According to the WHO, osteopenia is characterized by a value of BMD more than 1 standard deviation below the young adult mean, but less than 2 standard deviations below this value." [HPO:curators]
Show

 HP:0000939 Osteoporosis "Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility. According to the WHO, osteoporosis is characterized by a value of BMD 2.5 standard deviations or more below the young adult mean." [HPO:curators]
Show

 HP:0000956 Acanthosis nigricans 
Show

 HP:0000963 Thin skin 
Show

 HP:0001007 Hirsutism "Abnormally increased hair growth." [HPO:curators]
Show

 HP:0001371 Contractures 
Show

 HP:0001397 Hepatic steatosis 
Show

 HP:0001508 Failure to thrive 
Show

 HP:0001544 Prominent umbilicus "Abnormally prominent umbilicus (belly button)." [HPO:curators]
Show

 HP:0001635 Congestive heart failure "The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction." [HPO:curators]
Show

 HP:0001649 Tachycardia "A rapid heartrate that exceeds the range of the normal resting heartrate for age." [HPO:curators]
Show

 HP:0001657 Prolonged QT interval on EKG 
Show

 HP:0001662 Bradycardia 
Show

 HP:0001714 Ventricular hypertrophy 
Show

 HP:0001733 Pancreatitis 
Show

 HP:0001744 Splenomegaly "An abnormal enlargement of the spleen." [HPO:curators]
Show

 HP:0001962 Palpitations 
Show

 HP:0002015 Dysphagia "Difficulty in swallowing." [HPO:curators]
Show

 HP:0002019 Constipation 
Show

 HP:0002021 Pyloric stenosis 
Show

 HP:0002155 Hypertriglyceridemia 
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002595 Ileus "Acute obstruction of the intestines preventing passage of the contents of the intestines." [HPO:sdoelken]
Show

 HP:0002621 Atherosclerosis "A condition characterized by patchy atheromas or atherosclerotic plaques which develop in the walls of medium-sized and large arteries and can lead to arterial stenosis with reduced or blocked blood flow." [HPO:curators]
Show

 HP:0002650 Scoliosis "The presence of an abnormal lateral curvature of the spine." [HPO:curators]
Show

 HP:0002719 Recurrent infections 
Show

 HP:0002720 Decreased IgA 
Show

 HP:0002750 Delayed skeletal maturation "A decreased rate of skeletal maturation. Delayed skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body." [HPO:curators]
Show

 HP:0002910 Elevated transaminases "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage." [HPO:curators]
Show

 HP:0003198 Myopathy 
Show

 HP:0003236 Elevated serum creatine phosphokinase 
Show

 HP:0003306 Spinal rigidity 
Show

 HP:0003307 Hyperlordosis 
Show

 HP:0003324 Generalized muscle weakness "Generalized weakness or decreased strength of the muscles." [HPO:curators]
Show

 HP:0003326 Myalgia "A tendency to experience muscle pain." [HPO:curators]
Show

 HP:0003414 Atlantoaxial dislocation "Partial dislocation of the atlantoaxial joint." [HPO:curators]
Show

 HP:0003546 Exercise intolerance 
Show

 HP:0003552 Muscle stiffness 
Show

 HP:0003560 Muscular dystrophy "The term dystrophy means abnormal growth. However, muscular dystrophy is used to describe primary myopathies with a genetic basis and a progressive course characterized by progressive skeletal muscle weakness, defects in muscle proteins, and the apoptosis of muscle cells." [HPO:curators]
Show

 HP:0003593 Early onset 
Show

 HP:0003635 Loss of subcutaneous adipose tissue in limbs 
Show

 HP:0003701 Proximal muscle weakness "A lack of strength of the proximal muscles." [HPO:curators]
Show

 HP:0003712 Muscle hypertrophy "Hypertrophy (increase in size) of muscle cells (as opposed to hyperplasia, which refers to an increase in the number of muscle cells)." [HPO:curators]
Show

 HP:0003719 Muscle mounding 
Show

 HP:0003720 Generalized muscle hypertrophy "Hypertrophy (increase in size) of muscle cells in a generalized (not localized) distribution." [HPO:curators]
Show

 HP:0003738 Exercise-induced myalgia "The occurrence of an unusually high amount of muscle pain following exercise." [HPO:curators]
Show

 HP:0005110 Atrial fibrillation 
Show

 HP:0005184 Prolonged QTc interval 
Show

 HP:0009073 Muscle weakness, progressive, proximal "Lack of strength of the proximal muscles that becomes progressively more severe." [HPO:curators]
Show

 HP:0009125 Lipodystrophy "Degenerative changes of the fat tissue." [HPO:curators]
Show

 HP:0011968 Feeding difficulties "Impaired ability to eat related to problems gathering food and getting ready to suck, chew, or swallow it." [ISCA:eriggs]
Show

 HP:0012084 Abnormality of skeletal muscle fiber size "Any abnormality of the size of the `skeletal muscle cell` (FMA:9727)." [HPO:probinson]
Show

 HP:0040081 Abnormal levels of creatine kinase in blood 
Show

 HP:0100578 Lipoatrophy "Localized loss of fat tissue." [HPO:sdoelken]
Show

 HP:0100607 Dysmenorrhea 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000108312 UBTF / P17480 / upstream binding transcription factor, RNA polymerase I  / complex / reaction
 ENSG00000125482 TTF1 / Q15361 / transcription termination factor 1  / reaction / complex






 

1 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr